APA (7th ed.) Citation

Saghafi, F., Salehifar, E., Janbabai, G., Zaboli, E., Hedayatizadeh-Omran, A., Amjadi, O., & Moradi, S. (2018). CYP2D6*3 (A2549del), *4 (G1846A), *10 (C100T) and *17 (C1023T) genetic polymorphisms in Iranian breast cancer patients treated with adjuvant tamoxifen. Biomedical Reports, 9(5), 446. https://doi.org/10.3892/br.2018.1145

Chicago Style (17th ed.) Citation

Saghafi, Fatemeh, Ebrahim Salehifar, Ghasem Janbabai, Ehsan Zaboli, Akbar Hedayatizadeh-Omran, Omolbanin Amjadi, and Siavash Moradi. "CYP2D6*3 (A2549del), *4 (G1846A), *10 (C100T) and *17 (C1023T) Genetic Polymorphisms in Iranian Breast Cancer Patients Treated with Adjuvant Tamoxifen." Biomedical Reports 9, no. 5 (2018): 446. https://doi.org/10.3892/br.2018.1145.

MLA (9th ed.) Citation

Saghafi, Fatemeh, et al. "CYP2D6*3 (A2549del), *4 (G1846A), *10 (C100T) and *17 (C1023T) Genetic Polymorphisms in Iranian Breast Cancer Patients Treated with Adjuvant Tamoxifen." Biomedical Reports, vol. 9, no. 5, 2018, p. 446, https://doi.org/10.3892/br.2018.1145.